The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden
Open accessAbstract
Perivascular spaces that are visible on magnetic resonance imaging (MRI) are a neuroimaging marker of cerebral small vessel disease. Their location may relate to the type of underlying small vessel pathology: those in the white matter centrum semi-ovale have been associated with cerebral amyloid angiopathy, while those in the basal ganglia have been associated with deep perforating artery arteriolosclerosis. As cerebral amyloid angiopathy is an almost invariable pathological finding in Alzheimer's disease, we hypothesized that MRI-visible perivascular spaces in the centrum semi-ovale would be associated with a clinical diagnosis of Alzheimer's disease, whereas those in the basal ganglia would be associated with subcortical vascular cognitive impairment. We also hypothesized that MRI-visible perivascular spaces in the centrum semi-ovale would be associated with brain amyloid burden, as detected by amyloid positron emission tomography using 11C-Pittsburgh B compound (PiB-PET). Two hundred and twenty-six patients (Alzheimer's disease n = 110; subcortical vascular cognitive impairment n = 116) with standardized MRI and PiB-PET imaging were included. MRI-visible perivascular spaces were rated using a validated 4-point visual rating scale, and then categorized by severity ('none/mild', 'moderate' or 'frequent/severe'). Univariable and multivariable regression analyses were performed. Those with Alzheimer's disease-related cognitive impairment were younger, more likely to have a positive PiB-PET scan and carry at least one apolipoprotein E ɛ4 allele; those with subcortical vascular cognitive impairment were more likely to have hypertension, diabetes mellitus, hyperlipidaemia, prior stroke, lacunes, deep microbleeds, and carry the apolipoprotein E ɛ3 allele. In adjusted analyses, the severity of MRI-visible perivascular spaces in the centrum semi-ovale was independently associated with clinically diagnosed Alzheimer's disease (frequent/severe grade odds ratio 6.26, 95% confidence interval 1.66-23.58; P = 0.017, compared with none/mild grade), whereas the severity of MRI-visible perivascular spaces in the basal ganglia was associated with clinically diagnosed subcortical vascular cognitive impairment and negatively predicted Alzheimer's disease (frequent/severe grade odds ratio 0.03, 95% confidence interval 0.00-0.44; P = 0.009, compared with none/mild grade). MRI-visible perivascular space severity in either location did not predict PiB-PET. These findings provide further evidence that the anatomical distribution of MRI-visible perivascular spaces may reflect the underlying cerebral small vessel disease. Using MRI-visible perivascular space location and severity together with other imaging markers may improve the diagnostic value of neuroimaging in memory clinic populations, in particular in differentiating between clinically diagnosed Alzheimer's and subcortical vascular cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Self-citationPantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Pathologic correlates of incidental MRI white matter signal hyperintensities
Fazekas, F., Kleinert, R., Offenbacher, H., Schmidt, R., Kleinert, G., Payer, F., Radner, H., & Lechner, H. (1993) · Neurology · doi:10.1212/wnl.43.9.1683 · Cited by 1,619
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521 · cited 2×
“Alternatively CAA may disrupt perivascular drainage via perturbations in normal arteriolar pulsation (Hawkes et al., 2014; Kress et al., 2014).”
BackgroundImpairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Iliff, J. J., Chen, M. J., Plog, B. A., Zeppenfeld, D. M., Soltero, M., Yang, L., Singh, I., Deane, R., & Nedergaard, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3020-14.2014 · Cited by 1,159
Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease
Doubal, F. N., MacLullich, A. M. J., Ferguson, K. J., Dennis, M. S., & Wardlaw, J. M. (2010) · Stroke · doi:10.1161/strokeaha.109.564914 · Cited by 904
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Research criteria for subcortical vascular dementia in clinical trials
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K., Roman, G. C., Chui, H., & Desmond, D. W. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_4 · Cited by 631
Charidimou, A., Gang, Q., & Werring, D. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301308 · Cited by 611
Self-citationImaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000002175 · Cited by 423
Enlarged perivascular spaces are associated with cognitive function in healthy elderly men
MacLullich, A. M. J. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.030858 · Cited by 410
Cerebral amyloid angiopathy pathology and cognitive domains in older persons
Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383
Cerebrovascular disease in ageing and Alzheimer’s disease
Love, S., & Miners, J. S. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1522-0 · Cited by 299
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293
Roher, A. E., Kuo, Y.-M., Esh, C., Knebel, C., Weiss, N., Kalback, W., Luehrs, D. C., Childress, J. L., Beach, T. G., Weller, R. O., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402043 · Cited by 276
Charidimou, A., Meegahage, R., Fox, Z., Peeters, A., Vandermeeren, Y., Laloux, P., Baron, J.-C., Jager, H. R., & Werring, D. J. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304434 · Cited by 225
Self-citationDrowning stars: reassessing the role of astrocytes in brain edema
Thrane, A. S., Rangroo Thrane, V., & Nedergaard, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.010 · Cited by 220
Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy
Verbeek, M. M., Kremer, B. P. H., Rikkert, M. O., Van Domburg, P. H. M. F., Skehan, M. E., & Greenberg, S. M. (2009) · Annals of Neurology · doi:10.1002/ana.21694 · Cited by 202
White matter perivascular spaces: An MRI marker in pathology-proven cerebral amyloid angiopathy?
Charidimou, A., Jaunmuktane, Z., Baron, J.-C., Burnell, M., Varlet, P., Peeters, A., Xuereb, J., Jäger, R., Brandner, S., & Werring, D. J. (2014) · Neurology · doi:10.1212/01.wnl.0000438225.02729.04 · Cited by 186
Self-citationWhite Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid
Weller, R. O., Hawkes, C. A., Kalaria, R. N., Werring, D. J., & Carare, R. O. (2015) · Brain Pathology · doi:10.1111/bpa.12218 · Cited by 183
Self-citationIdentification of pure subcortical vascular dementia using 11 C-Pittsburgh compound B
Lee, J. H., Kim, S. H., Kim, G. H., Seo, S. W., Park, H. K., Oh, S. J., Kim, J. S., Cheong, H. K., & Na, D. L. (2011) · Neurology · doi:10.1212/wnl.0b013e318221acee · Cited by 179
Self-citationBath, P. M., & Wardlaw, J. M. (2015) · International Journal of Stroke · doi:10.1111/ijs.12466 · Cited by 178
Ramirez, J., Berezuk, C., McNeely, A. A., Scott, C. J. M., Gao, F., & Black, S. E. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132528 · Cited by 177
Biomarkers in dementia: clinical utility and new directions
Ahmed, R. M., Paterson, R. W., Warren, J. D., Zetterberg, H., O'Brien, J. T., Fox, N. C., Halliday, G. M., & Schott, J. M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307662 · Cited by 174
Samarasekera, N., Smith, C., & Salman, R. A. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300371 · Cited by 165
Topography of dilated perivascular spaces in subjects from a memory clinic cohort
Martinez-Ramirez, S., Pontes-Neto, O. M., Dumas, A. P., Auriel, E., Halpin, A., Quimby, M., Gurol, M. E., Greenberg, S. M., & Viswanathan, A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f1876 · Cited by 163
Failure of Perivascular Drainage of β‐amyloid in Cerebral Amyloid Angiopathy
Hawkes, C. A., Jayakody, N., Johnston, D. A., Bechmann, I., & Carare, R. O. (2014) · Brain Pathology · doi:10.1111/bpa.12159 · Cited by 163
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
Weller, R. O., Preston, S., Subash, M., & Carare, R. O. (2009) · Alzheimer s Research & Therapy · doi:10.1186/alzrt6 · Cited by 161
Ischemic brain injury in cerebral amyloid angiopathy
Reijmer, Y. D., van Veluw, S. J., & Greenberg, S. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.88 · Cited by 158
Outcome markers for clinical trials in cerebral amyloid angiopathy
Greenberg, S. M., Salman, R. A., Biessels, G. J., van Buchem, M. A., Cordonnier, C., Lee, J., Montaner, J., Schneider, J. A., Smith, E. E., Vernooij, M. W., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70003-1 · Cited by 155
Self-citationTopography and associations of perivascular spaces in healthy adults: The Kashima Scan Study
Yakushiji, Y., Charidimou, A., Hara, M., Noguchi, T., Nishihara, M., Eriguchi, M., Nanri, Y., Nishiyama, M., Werring, D. J., & Hara, H. (2014) · Neurology · doi:10.1212/wnl.0000000000001054 · Cited by 131
Self-citationCerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces
van Veluw, S. J., Biessels, G. J., Bouvy, W. H., Spliet, W. G. M., Zwanenburg, J. J. M., Luijten, P. R., Macklin, E. A., Rozemüller, A. J. M., Gurol, M. E., Greenberg, S. M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15620434 · Cited by 115
Lee, M. J., Seo, S. W., Na, D. L., Kim, C., Park, J. H., Kim, G. H., Kim, C. H., Noh, Y., Cho, H., Kim, H. J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4506 · Cited by 111
Self-citationSeo, S. W., Cho, S. S., Park, A., Chin, J., & Na, D. L. (2009) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2008.00292.x · Cited by 99
Self-citationCharidimou, A., Hong, Y. T., Jäger, H. R., Fox, Z. V., Aigbirhio, F. I., Fryer, T. D., Menon, D. K., Warburton, E. A., Werring, D. J., & Baron, J. (2015) · Stroke · doi:10.1161/strokeaha.115.009090 · Cited by 96
Self-citationCharidimou, A., Jäger, H. R., Peeters, A. P., Vandermeeren, Y., Laloux, P., Baron, J., & Werring, D. J. (2014) · Stroke · doi:10.1161/strokeaha.114.005568 · Cited by 57
Self-citationJeon, S., Yoon, U., Park, J., Seo, S. W., Kim, J., Kim, S. T., Kim, S. I., Na, D. L., & Lee, M.-J. (2011) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.20277 · Cited by 54
Self-citationRelationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
Williams, S., Chalmers, K., Wilcock, G. K., & Love, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00663.x · Cited by 49
Jeynes, B., & Provias, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0099-z · Cited by 34
Sachdev, P. S., Wen, W. X., Shnier, R., & Brodaty, H. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.1.83 · Cited by 31
Arima, K., Izumiyama, Y., Nakamura, M., Nakayama, H., Kimura, M., Ando, S., Ikeda, K., & Takahashi, K. (1998) · Acta Neuropathologica · doi:10.1007/s004010050762 · Cited by 18
Amyloid plaques and intraneuronal tau inclusions in A‐beta‐related angiitis (ABRA)
Kurian, M., Burkhardt, K., Assal, F., Kövari, E., & Horvath, J. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01245.x · Cited by 11
Cited by
Kamagata, K., Andica, C., Takabayashi, K., Saito, Y., Taoka, T., Nozaki, H., Kikuta, J., Fujita, S., Hagiwara, A., Kamiya, K., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201300 · Cited by 379
Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy
Owasil, R., O’Neill, R., Keable, A., Nimmo, J., MacGregor Sharp, M., Kelly, L., Saito, S., Simpson, J. E., Weller, R. O., Smith, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041225 · Cited by 48
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease
Littau, J. L., Velilla, L., Hase, Y., Villalba‐Moreno, N. D., Hagel, C., Drexler, D., Osorio Restrepo, S., Villegas, A., Lopera, F., Vargas, S., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13097 · Cited by 20
Metadata
- Authors
- Banerjee, G., Kim, H. J., Fox, Z., Jäger, H. R., Wilson, D., Charidimou, A., Na, H. K., Na, D. L., Seo, S. W., & Werring, D. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-17
- Volume
- 140
- Issue
- 4
- Pages
- 1107-1116
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2602043626
- Cited by
- 254
- References
- 46
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.